Cogent Biosciences, Inc.
COGTCIK 0001622229 · Every Form 4 filed by insiders at this issuer.
Filings
8
Latest Feb 16, 2024
Unique insiders
8
Showing
8 of 8
Page 1
Top insiders
Most active reporters at Cogent Biosciences, Inc.
| Name | Roles | Filings |
|---|---|---|
| Fairmount Funds Management LLC | 10% Owner | 1 |
| Ferrante Karen Jean | Director | 1 |
| Green John L. | Officer | 1 |
| Kearns Evan | Officer | 1 |
| Robbins Andrew R | OfficerDirector | 1 |
| Robinson John Edward | Officer | 1 |
| Ros Matthew | Director | 1 |
| Sachs Jessica | Officer | 1 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | Fairmount Funds Management LLC 10% Owner | A | 1,166,666 | $7.50 | $8,749,995 | |
| Jan 25, 2024 | Green John L. Chief Financial Officer | Holdings only | — | — | — | |
| Jan 25, 2024 | Robbins Andrew R President and CEO · Director | Holdings only | — | — | — | |
| Jan 25, 2024 | Sachs Jessica Chief Medical Officer | Holdings only | — | — | — | |
| Jan 25, 2024 | Kearns Evan Chief Legal Officer | Holdings only | — | — | — | |
| Jan 25, 2024 | Robinson John Edward Chief Scientific Officer | Holdings only | — | — | — | |
| Jan 4, 2024 | Ros Matthew Director | Holdings only | — | — | — | |
| Jan 4, 2024 | Ferrante Karen Jean Director | Holdings only | — | — | — |
Showing 1–8 of 8
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.